Evidence map›Paper›PMID 35911064›Full record

ArticleJournal of cardiology cases2022

A double heterozygous variant in

Takanori Suzuki, Kazuyoshi Saito, Tetsushi Yoshikawa, Keichi Hirono, Yukiko Hata, Naoki Nishida, Kazushi Yasuda, Masami Nagashima

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cardiology cases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Early Cytoskeletal Remodeling Drives Hypertrophic Cardiomyopathy Pathogenesis inJournal of cardiovascular development and disease · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. MYH7 in cardiomyopathy and skeletal muscle myopathy.Molecular and cellular biochemistry · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Takanori SuzukiDepartment of Pediatric Cardiology, Aichi Children's Health and Medical Center, Aichi, Japan.
Kazuyoshi SaitoDepartment of Pediatric Cardiology, Aichi Children's Health and Medical Center, Aichi, Japan.
Tetsushi YoshikawaDepartment of Pediatrics, School of Medicine, Fujita Health University, Aichi, Japan.
Keichi HironoDepartment of Pediatrics, Graduate School of Medicine, University of Toyama, Toyama, Japan.
Yukiko HataDepartment of Legal Medicine, Graduate School of Medicine University of Toyama Hospital, Toyama, Japan.
Naoki NishidaDepartment of Legal Medicine, Graduate School of Medicine University of Toyama Hospital, Toyama, Japan.
Kazushi YasudaDepartment of Pediatric Cardiology, Aichi Children's Health and Medical Center, Aichi, Japan.
Masami NagashimaDepartment of Pediatric Cardiology, Aichi Children's Health and Medical Center, Aichi, Japan.
Fujita Health University · JPToyama University Hospital · JPUniversity of Toyama · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertrophic cardiomyopathy (HCM) is genetically heterogeneous. Different variants associated with HCM have been identified in several cardiac sarcomeric protein genes. We identified the heterozygous missense variant c.2191

Indexed as

Cardiac sarcomeric protein genesHeterozygous missense variantHypertrophic cardiomyopathy

Identifiers

PMID35911064
PMCPMC9326009
OpenAlexW3210078611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.